Microbiology & Infectious Diseases

A single genetic mutation in the bovine influenza H5N1 virus may have the potential to adapt to human hosts.

Patients with cancer vaccinated against COVID-19 within 6 months before infection showed significantly higher survival rates, according to a new analysis from the ASCO COVID-19 Registry.

A retrospective study highlighted the effectiveness of remdesivir in reducing 30-day COVID-19-related readmissions among vulnerable patient populations, including older adults and those with immunocompromising conditions.

Chronic exposure to cigarette smoke (CS) may significantly worsen the severity of influenza A virus (IAV) infections, not only through direct lung damage but also via changes in the microbiota.

Twice-yearly lenacapavir injections have shown remarkable efficacy in preventing HIV infection, offering a promising alternative to daily oral PrEP for males and gender-diverse individuals.

The response to tamoxifen, a cornerstone drug in preventing breast cancer recurrence, may hinge on an unexpected factor: gut bacteria.

Pandrug-resistant Klebsiella pneumoniae strains isolated from Ukrainian war victims are raising red flags for healthcare professionals worldwide.

A new study highlights partial resistance to artemisinin in Ugandan children with severe malaria, raising concerns about the efficacy of frontline treatments in sub-Saharan Africa.